Exercise intolerance in patients with chronic heart failure and increased expression of inducible nitric oxide synthase in the skeletal muscle

Journal of the American College of Cardiology

Volumn 33, Issue 1, 1999, Pages 174-179

  Hambrecht, Rainer ^a   Adams, Volker ^a   Gielen, Stephan ^a   Linke, Axel ^a   Möbius Winkler, Sven ^a   Jiangtao, Y U ^a   Niebauer, Josef ^a   Jiang, Hong ^a   Fiehn, Eduard ^a   Schuler, Gerhard ^a  

^a UNIVERSITY OF LEIPZIG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CREATINE KINASE; CREATINE PHOSPHATE; MITOCHONDRIAL ENZYME; NITRIC OXIDE SYNTHASE;

ADULT; AGED; ANIMAL CELL; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME INDUCTION; EXERCISE TOLERANCE; HEART FAILURE; HUMAN; HUMAN TISSUE; MUSCLE BIOPSY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SKELETAL MUSCLE;

AGED; ANIMALS; CREATINE KINASE; ENZYME INDUCTION; EXERCISE TEST; HEART FAILURE, CONGESTIVE; HUMANS; MALE; MITOCHONDRIA, MUSCLE; MUSCLE, SKELETAL; NITRIC OXIDE SYNTHASE; PHYSICAL ENDURANCE; RATS;

EID: 0032952023     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0735-1097(98)00531-2     Document Type: Article

References (32)

1. Kossmann CE, Chasis H, Foley WT, et al. Physical capacity of heart disease. In: The Nomenclature Committee of the New York Heart Association, editors. Diseases of the Heart and Blood Vessels. London:Churchill, 1949:112-3.
2. Franciosa JA, Park M, Levine TB. Lack of correlation between exercise capacity and indexes of resting left ventricular performance in heart failure. Am J Cardiol 1981;47:33-9.
3. Myers J, Fröhlicher VF. Hemodynamic determinants of exercise capacity in chronic heart failure. Ann Intern Med 1991;115:377-86.
4. Drexler H, Riede U, Münzel T, König H, Funke E, Just H. Alterations of skeletal muscle in chronic heart failure. Circulation 1992;85:1751-9.
5. Wilson JR, Mancini DM, Dunkman WB. Exertional fatigue due to skeletal muscle dysfunction in patients with heart failure. Circulation 1993;87:470-5.
6. Sullivan MJ, Green HJ, Cobb FR. Skeletal muscle biochemistry and histology in ambulatory patients with long-term heart failure. Circulation 1990;81:518-27.
7. Minotti JR, Christoph I, Oka R, Weiner MW, Wells I, Massie BM. Impaired skeletal muscle function in patients with congestive heart failure: relationship to systemic exercise performance. J Clin Invest 1991;88:2077-82.
8. Mancini DM, Walter G, Reichek N, Lenkinski R, McCully KK, Mullen JL, Wilson JR. Contribution of skeletal muscle atrophy to exercise intolerance and altered muscle metabolism in heart failure. Circulation 1992;85:1364-73.
9. Mancini DM, Coyle E, Coggan A, Beltz J, Ferraro N, Montain S, Wilson JR. Contribution of intrinsic skeletal muscle changes to 31-P NMR Skeletal muscle metabolic abnormalities in patients with chronic heart failure. Circulation 1989;80:1338-46.
10. Massie BM, Conway M, Yonge R, Frostick S, Ledingham J, Sleight P, Radda G, Rajagopalan B. Skeletal muscle metabolism in patients with congestive heart failure: relation to clinical severity and blood flow. Circulation 1987;78:1009-19.
11. Wallimann T, Wyss M, Brdiczka D, Nicolay K, Eppenberger HM. Intracellularcompartmentation, structure and function of creatine kinase isoenzymes in tissues with high and fluctuating energy demands: the "phosphocreatine circuit" for cellular energy homeostasis. Biochem J 1992;281:21-40.
12. Wilson JR, Martin JL, Schwartz D, Ferraro N. Exercise intolerance in patients with chronic heart failure: role of impaired nutritive flow to skeletal muscle. Circulation 1984;69:1079-87.
13. Wiener DH, Fink LI, Maris J, Jones RA, Chance B, Wilson JR. Abnormal skeletal muscle bioenergetics during exercise in patients with heart failure: role of reduced muscle blood flow. Circulation 1986;73:1127-36.
14. Hambrecht R, Niebauer J, Fiehn E, et al. Physical training in patients with stable chronic heart failure: effects on cardiorespiratory fitness and ultrastructural abnormalities of leg muscle. J Am Coll Cardiol 1995;25:1239-49.
15. Hambrecht R, Fiehn E, Yu J, Niebauer J, Weigl C, Hilbrich L, Adams V, Riede U, Schuler G. Effects of endurance training on mitochondrial ultrastructure and fiber type distribution in skeletal muscle of patients with stable chronic heart failure. J Am Coll Cardiol 1997;29:1067-73.
16. Adams V, Yu J, Möbius-Winkler S, Linke A, Weigl C, Hilbrich L, Schuler G, Hambrecht R. Increased nitric oxide synthase in skeletal muscle biopsies from patients with chronic heart failure. Biochem Mol Med 1997;61:152-60.
17. Riede UN, Förstermann U, Drexler H. Inducible nitric oxide synthase in skeletal muscle of patients with chronic heart failure. J Am Coll Cardiol 1997;29Suppl:423A.
18. Cleeter MW, Cooper JM, Darley-Usmar VM, Moncada S, Schapira AH. Reversible inhibition of cytochrome C oxidase, the terminal enzyme of the mitochondrial respiratory chain, by nitric oxid. Implications for neurodegenerative diseases. FEBS Lett 1994;345:50-4.
19. Wassermann K, Whipp BJ, Koyal SH, Beaver WL. Anaerobic threshold and respiratory gas exchange during exercise. J Appl Physiol 1973;35:236-43.
20. Wobus AM, Kaomei G, Shan J, Wellner MC, Rohwedel J, Ji G, Fleischmann B, Katus HA, Hescheler J, Franz WM. Retinoic acid accelerates embryonic stem cell-derived cardiac differentiation and enhances development of ventricular cardiomyocytes. J Mol Cell Cardiol 1997;29(6):1525-39.
21. Chomczynski P, Sacchi N. Single step method of RNA isolation by acid guanidinium thiocyanaze-phenol-chloroform extraction. Anal Biochem 1987;162:156-9.
22. Bachmaier K, Neu N, Pummerer C, Duncan GS, Mak TW, Matsuyama T, Penninger JM. iNOS expression and nitrotyrosine formation in the myocardium in response to inflammation is controlled by the interferon regulatory transcription factor 1. Circulation 1997;96:585-91.
23. Adams V, Bosch W, Schlegel J, Wallimann T, Brdiczka D. Further characterization of contact sites from mitochondria of different tissues: topology of peripheral kinases. Biochem Biophys Acta 1989;981:213-25.
24. Srere PA. Reactions on the cycle: citrate synthase. In: Colowick SP, Kaplan NO, editors. Methods in Enzymology. New York: Academic Press, 1969,3-5.
25. Towbin H, Staehelin T, Gordon J. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedures and some applications. Proc Nat Acad Sci USA 1979;76:4350-4.
26. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with the Folin phenol reagent. J Biol Chem 1951;193:265-75.
27. Massie BM, Conway M, Rajagopalan B, Yonge R, Frostick S, Ledigham J, Sleight P, Radda G. Skeletal muscle metabolism during exercise under ischemic conditions in congestive heart failure. Circulation 1988;78:320-6.
28. Gross SS, Wolin MS. Nitric oxide: pathophysiological mechanisms. Ann Rev Physiol 1995;57:737-69.
29. Bredt DS, Snyder SH. Nitric oxide: a physiologic messenger molecule. Ann Rev Biochem 1994;63:175-95.
30. Wolosker H, Panizutti R, Engelender S. Inhibition of creatine kinase by S-nitrosoglutathione. FEBS Lett 1998;392:274-6.
31. Gross WL, Bak M, Ingwall JS, Arstall MA, Smith TW, Balligand J, Kelly RA. Nitric oxide inhibits creatine kinase and regulates rat heart contractile reserve. Proc Natl Acad Sci USA 1996;93:5604-9.
32. Rose IA, Warms JVB. Stability of hexokinase II in vitro and in ascites tumor cells. Arch Biochem Biophys 1982;213:625-34.